Moderna Shares Slide After Posting a Loss on Falling COVID-19 Vaccine Sales and ProductionInvestopedia • 11/02/23
Moderna (MRNA) Beats on Q3 Earnings & Sales, Expects Lower COVID DemandZacks Investment Research • 11/02/23
Today's Market Movers: Starbucks (SBUX) and Qualcomm (QCOM) Popping Off While SolarEdge (SEDG) and Moderna (MRNA) Down Big24/7 Wall Street • 11/02/23
Moderna Reports Third Quarter 2023 Financial Results and Provides Business UpdatesAccesswire • 11/02/23
Exploring Analyst Estimates for Moderna (MRNA) Q3 Earnings, Beyond Revenue and EPSZacks Investment Research • 11/01/23
Among the S&P 500, these 20 companies have made the best use of investors' moneyMarket Watch • 10/25/23
Moderna's stock snaps record losing streak as Cathie Wood's ETF boosts stake by more than $4 millionMarket Watch • 10/24/23
Moderna and Caris Life Sciences partner to develop mRNA oncology therapeuticsProactive Investors • 10/24/23
Moderna Announces First Participant Dosed in Phase 3 Study of mRNA-1083, a Combination Vaccine Against Influenza and COVID-19Accesswire • 10/24/23
Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology TherapeuticsPRNewsWire • 10/24/23
Moderna's stock suffering record losing streak as ‘investor caution remains high' over COVID vaccine salesMarket Watch • 10/23/23